n/a (ARDX)

: ARDX · Precio en tiempo real · USD

n/a

n/a (n/a)

Al cierre: Invalid Date

El precio, las cifras principales y las últimas noticias, en un solo sitio.

No hay datos disponibles

Precio de compra	n/a
Capitalización de mercado	n/a
Ingresos (TTM)	n/a
Beneficio neto (TTM)	n/a
	n/a
	n/a
	n/a
	n/a
P/B (TTM)	n/a
P/S (TTM)	n/a
Fecha de resultados	n/a

Precio de venta	n/a
Volumen	NaN
Volumen medio (20D)	n/a
Abierto	n/a
Anterior Cerrar	n/a
Rango del día	n/a - n/a
Rango de 52 semanas	n/a - n/a
analista	n/a
Precio objetivo	n/a
Dividendos	n/a
Fecha ex dividendo	n/a

Acerca de ARDX

A detailed description of the company is not yet available....

[Leer más]

Industria n/a

Sector n/a

IPO Fecha n/a

Empleados n/a

Bolsa de Valores n/a

Símbolo bursátil ARDX

Perfil completo de la empresa

Sorpresa de resultados

ha publicado sus resultados trimestrales en Aug 6, 2026:

Ingresos de $120.88M falla las estimaciones por $0, con 23.77% Crecimiento interanual.
EPS de -0.07 falla las estimaciones por -0.02, con -450.00% Disminución interanual.

Noticias

2 semanas hace · Motley Fool

Ardelyx (ARDX) Q2 2026 Earnings Call Transcript

Record revenue masks payer headwinds forcing IBSRELA guidance cuts.

2 semanas hace · Simply Wall St.

Ardelyx (ARDX) Is Down 19.7% After Raising IBSRELA Revenue Guidance And Narrowing Losses

In August 2026, Ardelyx, Inc. reported second-quarter 2026 results showing revenue of US$120.88 million versus US$97.66 million a year earlier, with net loss narrowing to US$16.72 million and basic lo...

3 semanas hace · Simply Wall St.

Ardelyx (ARDX) Posts Record Revenue, Is The Stock Still 70% Undervalued?

Ardelyx (ARDX) is back in focus after reporting record Q2 2026 revenue driven by IBSRELA and XPHOZAH, while missing earnings estimates and trimming IBSRELA guidance because of payer related hurdles. S...

3 semanas hace · Zacks

New Strong Sell Stocks for August 7th

ARDX, ARDT and GPRE have been added to the Zacks Rank #5 (Strong Sell) List on August 7th, 2026.

3 semanas hace · GuruFocus.com

Ardelyx Inc (ARDX) (Q2 2026) Earnings Call Highlights: Record Revenue of $118M Driven by Strong ...

Ardelyx Inc (ARDX) delivers 31% revenue growth in Q2 2026 while navigating payer-imposed challenges that led to a lowered Ibsrela outlook and withdrawal of Xphozah guidance.

Página 1 de 2